Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | HCID 14675937 | HCID 14675937 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 70069849 | HCID 70069849 | — |
Reaction Steps
1.3 g of dihydrobromide of the B-isomer of ethyl 3-[1(R)-ethoxycarbonyl-2-{2-(4-piperidyl)ethylthio}ethyl]amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-1-acetate obtained in Example 5 is dissolved in 10 ml of an aqueous solution of 50% methanol, and the resulting solution is gradually added dropwise to 15.5 ml of an aqueous solution of 2N sodium hydroxide. After stirring for 2 hours at room temperature, the reaction liquid is neutralized with 6.5 ml of acetic acid. The residue obtained by concentration under reduced pressure is purified by HP-20 column chromatography (water:methanol=3:1). The solvent is evaporated under reduced pressure, and the resulting residue is lyophilized to give 440 mg of the B-isomer of 3-[1(R)-carboxy-2-{2-(4-piperidyl)ethylthio}ethyl]amino-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-1-acetic acid monohydrate as a colorless powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04882326 |
|---|
| Source dataset | uspto-grants-1989_11 |
|---|
| ORD ID | ord-b93cc19eb1a04255a992af8801d02077 |
|---|
| Source note | uspto-grants-1989_11 |
|---|